等待開盤 03-27 09:30:00 美东时间
-0.015
-1.36%
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31
今日重点评级关注:Piper Sandler:维持Allogene疗法"超配"评级,目标价从7美元升至8美元;B. Riley证券:维持Oncology Institute"买入"评级,目标价从6美元升至8美元
03-16 18:19
Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during ...
03-13 05:05
Health Catalyst shares are trading lower after the company reported mixed Q4 fi...
03-13 04:43
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Health Catalyst Inc. Updates Financial Calendar Health Catalyst Inc. will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026, after market close. The company will host a conference call to review the results at 5:00 pm ET the same day, with a live audio webcas
03-02 21:03
Health Catalyst will release its Q4 and 2025 financial results on March 12, 2026, after market close. A conference call to discuss the results will be held at 5:00 PM ET on the same day. Participants can join by dialing 800-343-5172 (U.S.) or 203-518-9856 (international) with conference ID "HCATQ425." A live webcast will be available at https://ir.healthcatalyst.com/, and a replay will be accessible for 90 days. Health Catalyst is a leading provi...
03-02 13:00
Health Catalyst (HCAT) on Wednesday announced that Ben Albert, its president and chief operating officer, has been named as the company’s new chief executive and a member of the board, effective Feb. ...
02-18 23:33
Health Catalyst ( ($HCAT) ) has shared an update. On February 12, 2026, Health ...
02-18 22:18
Albert to Sharpen Focus on Improving Cost and Operational Efficiency,Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five DirectorsImmediately Prior to the 2026 Annual
02-18 21:59